Komori
Japan Tissue Engineering (7774) · InitiativeFirst stated

ジャック's Expansion into Knee Osteoarthritis Treatment through Private-Pay Care and Medical Tourism

First written in FY2026. . Latest entry: FY2026.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Jack knee osteoarthritis treatment: private-pay care and medical tourism expansionA theme 1 companies write about · 0 as a headwind · 1 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2026First statedAnnual report

    「In the knee field, we will work with medical institutions that are heavy users to begin private-pay treatment for the condition, including medical tourism, and pursue rapid expansion following approval.」

    As a new initiative following the expansion of JACC's indications for knee osteoarthritis, we have presented for the first time a policy of beginning private-pay care and medical tourism in collaboration with medical institutions that are heavy users.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
Japan Tissue Engineering's next results are scheduled for 2026-10-30. Read the earnings preview
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.